Tai Chi for Chronic Obstructive Pulmonary Disease (COPD): An Overview of Systematic Reviews

References

• Global Strategy for the Diagnosis. Management and prevention of chronic obstructive pulmonary disease (2019 REPORT). the guide and the complete list of references examined by the committee are available on the GOLD. Available from: www.goldcopd.org. Accessed May 27, 2021.
   Google Scholar
• Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.00025805
   PubMed Web of Science ®Google Scholar
• GBoDS Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-2
   PubMed Web of Science ®Google Scholar
• Celli BR. Management Guidelines for Chronic Obstructive Pulmonary Disease. In: Hanania N, Sharafkhaneh A (eds). COPD. Respiratory Medicine. Humana Press; 2011:81-98. https://doi.org/10.1007/978-1-59745-357-8_5
   Google Scholar
• Gómez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2002;8(2):81. doi:10.1097/00063198-200203000-00001
   PubMed Web of Science ®Google Scholar
• Hempel S, Taylor SL, Solloway MR, et al. Evidence Map of Tai Chi. Department of Veterans Affairs; 2014.
   Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet. 1998;351(9096):123–127. doi:10.1016/S0140-6736(97)08468-7
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Orland BI. The importance and impact of evidence based medicine. J Manag Care Pharm. 2004;10(5 Supp A):S3. doi:10.18553/jmcp.2004.10.S5-A.S3
   PubMedGoogle Scholar
• Katrina A, Freeman EE, Robert D. The role of systematic reviews and meta-analysis in dermatology. J Invest Dermatol. 2012;132(11):e2.
   Web of Science ®Google Scholar
• Wu LL, Lin ZK, Weng HD, et al. Effectiveness of meditative movement on COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1239–1250. doi:10.2147/COPD.S159042
   PubMed Web of Science ®Google Scholar
• Ngai SP, Jones AY, Tam WW. Tai Chi for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2016;6(6):CD009953.
   Google Scholar
• Liu JP. Methodological quality assessment of clinical trials in traditional Chinese medicine: the principles of evidence-based medicine. Zhong Xi Yi Jie He Xue Bao. 2006;4(1):1.
   PubMedGoogle Scholar
• Page MJ, Moher D. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263. doi:10.1186/s13643-017-0663-8
   PubMed Web of Science ®Google Scholar
• Page M, Shamseer L, Altman D, et al. Epidemiology and reporting characteristics of systematic reviews of biomedical research: a Cross-Sectional Study. PLoS Med. 2016;13(5):e1002028. doi:10.1371/journal.pmed.1002028
   PubMed Web of Science ®Google Scholar
• Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–276. doi:10.1016/S0140-6736(13)62228-X
   PubMed Web of Science ®Google Scholar
• David M, Alessandro L, Jennifer T, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Rev Española De Nutrición Hum Y Diet. 2009;18(3):e123.
   Google Scholar
• Hartling L, Chisholm A, Thomson D, et al. A descriptive analysis of overviews of reviews published between 2000 and 2011. PLoS One. 2012;7(11):e49667. doi:10.1371/journal.pone.0049667
   PubMed Web of Science ®Google Scholar
• Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. doi:10.1136/bmj.j4008
   PubMed Web of Science ®Google Scholar
• Farquhar CM, Showell MG, Eae S, et al. Clinical trial registration was not an indicator for low risk of bias. J Clin Epidemiol. 2017;84:47. doi:10.1016/j.jclinepi.2016.11.011
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Br J Surg. 2000;23(6):1448–1454.
   Google Scholar
• Zorzela L, Loke YK, Ioannidis JP, et al. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157. doi:10.1136/bmj.i157
   PubMed Web of Science ®Google Scholar
• Stewart LA, Mike C, Maroeska R, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. J Am Med Assoc. 2015;313(16):1657–1665. doi:10.1001/jama.2015.3656
   PubMed Web of Science ®Google Scholar
• Schünemann H, Brożek J, Guyatt G, et al. The GRADE handbook. 2013. Available from: https://gdt.gradepro.org/app/handbook/handbook.html#h.hnedbo8gqjqk. Accessed May 27, 2021.
   Google Scholar
• Wei S, Huan Z, Wei C, et al. A meta-analysis of the effect of taijiquan exercise on pulmonary function rehabilitation in patients with stable chronic obstructive pulmonary disease. Chin J Rehabil Med. 2016.
   Google Scholar
• Tian L, Li L, Zhang Y, et al. A meta-analysis of the effect of taijiquan on the rehabilitation of patients with stable chronic obstructive pulmonary disease. Chin J Gerontol. 2015.
   Google Scholar
• Wang J, Liu X, Jun H, et al. Effects of Tai Chi exercise on lung function and exercise endurance of old patients with chronic obstructive pulmonary disease: a meta-analysis. Chin J Tissue Eng Res. 2015;5:815–820.
   Google Scholar
• Wang L, Gao L. Meta analysis of intervention effect of taijiquan on elderly patients with COPD. J Guangzhou Sport Univ. 2020;40(6):95–101.
   Google Scholar
• Wang C, Zhou L. Meta-analysis of the effects of taijiquan on lung function, exercise ability and quality of life in patients with chronic obstructive pulmonary disease. J Mod Med. 2020;36(22):3651–3656.
   Google Scholar
• Dong J, Ji Y, Ge Y. Meta-analysis of Tai Chi exercise on rehabilitation of middle-aged and elderly patients with chronic obstructive pulmonary disease. J Jilin Sport Univ. 2021;37:1.
   Google Scholar
• Guo JB, Chen BL, Lu YM, et al. Tai Chi for improving cardiopulmonary function and quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clin Rehabil. 2016;30(8):750. doi:10.1177/0269215515604903
   PubMed Web of Science ®Google Scholar
• Wu W, Liu X, Wang L, et al. Effects of Tai Chi on exercise capacity and health-related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;2014:1253–1263. doi:10.2147/COPD.S70862
   Web of Science ®Google Scholar
• Jun-Hong Y, Yong-Zhong G, Hong-Mei Y, et al. Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PLoS One. 2013;8(4):e61806. doi:10.1371/journal.pone.0061806
   PubMed Web of Science ®Google Scholar
• Guo C, Xiang G, Xie L, et al. Effects of Tai Chi training on the physical and mental health status in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis. 2020;12(3):504–521. doi:10.21037/jtd.2020.01.03
   PubMed Web of Science ®Google Scholar
• Chen Y-W, Hunt MA, Campbell KL, et al. The effect of Tai Chi on four chronic conditions—cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: a systematic review and meta-analyses. Br J Sports Med. 2016;50(7):397–407. doi:10.1136/bjsports-2014-094388
   PubMed Web of Science ®Google Scholar
• Berry CE, Drummond MB, Han MK, et al. Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest. 2012;142(3):704–711. doi:10.1378/chest.11-1332
   PubMed Web of Science ®Google Scholar
• Donohue JF. Minimal clinically important differences in COPD lung function. J Chronic Obstr Pulm Dis. 2005;2(1):111–124. doi:10.1081/COPD-200053377
   Google Scholar
• Lu M, Yao WZ. [Interpretation of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (GOLD) 2016]. Zhonghua Yi Xue Za Zhi. 2016;96(34):2689. Chinese.
   PubMedGoogle Scholar
• Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010;104(6):849–857. doi:10.1016/j.rmed.2009.12.007
   PubMed Web of Science ®Google Scholar
• Crapo RO, Casaburi R, Coates AL, et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Hernandes NA, Wouters EFM, Meijer K, et al. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J. 2011;38(2):261–267. doi:10.1183/09031936.00142010
   PubMed Web of Science ®Google Scholar
• Puhan MA, Mador MJ, Held U, et al. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2009;5(2):56.
   Google Scholar
• Weatherall M, Marsh S, Shirtcliffe P, et al. Quality of life measured by the St George’s respiratory questionnaire and spirometry. Eur Respir J. 2009;33(5):1025–1030. doi:10.1183/09031936.00116808
   PubMed Web of Science ®Google Scholar
• Sanchez FF, Faganello MM, Tanni SE, et al. Relationship between disease severity and quality of life in patients with chronic obstructive pulmonary disease. Braz J Med Biol Res. 2008;41(10):860. doi:10.1590/S0100-879X2008005000043
   PubMed Web of Science ®Google Scholar
• Sideri S, Papageorgiou SN, Eliades T. Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. J Clin Epidemiol. 2018;100:103–110. doi:10.1016/j.jclinepi.2018.01.003
   PubMed Web of Science ®Google Scholar
• Xu C, Cheng -L-L, Liu Y, et al. Protocol registration or development may benefit the design, conduct and reporting of dose-response meta-analysis: empirical evidence from a literature survey. BMC Med Res Methodol. 2019;19(1):78. doi:10.1186/s12874-019-0715-y
   PubMed Web of Science ®Google Scholar
• Ge L, Tian JH, Li YN, et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. J Clin Epidemiol. 2018;93:45–55. doi:10.1016/j.jclinepi.2017.10.012
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi:10.1016/0197-2456(95)00134-4
   PubMedGoogle Scholar
• Koletsi D, Fleming PS, Michelaki I, et al. Heterogeneity in cochrane and non-cochrane meta-analyses in orthodontics. J Dent. 2018;74:S0300571218301106. doi:10.1016/j.jdent.2018.05.003
   Web of Science ®Google Scholar
• Tacconelli E. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis. 2010;10(4):226. doi:10.1016/S1473-3099(10)70065-7
   Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [Updated February 2008]. The Cochrane Collaboration; 2008.
   Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343(jul22 1):d4002. doi:10.1136/bmj.d4002
   PubMed Web of Science ®Google Scholar